Bavarian Nordic Presents New Clinical Data on PROSTVAC® at the 2013 Genitourinary Cancers Symposium

World News: . []

KVISTGAARD Denmark - February 13 2013 - Bavarian Nordic AS OMX BAVA today announced that four abstracts on the Companys therapeutic cancer vaccine candidates for the treatment of prostate cancer, PROSTVAC and MVA-BN PRO will be the subje ct of f...

More news and information about Bavarian Nordic A/S

Published By:

Thomson Reuters: 07:01 GMT Wednesday 13th February 2013

Published: .

Search for other references to "bavarian" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers